RPSA and lung carcinoma: Thus, the downregulation of LRP/LR causes an almost complete inhibition of telomerase activity in the A549 lung cancer cells, and as such, targets the cells' ability for replicative immortality, therefore referring to the inhibition of the ‘Enabling replicative immortality’ cancer hallmark.